MSB 4.07% $1.15 mesoblast limited

Cell Therapy News/Articles, page-4148

  1. 509 Posts.
    lightbulb Created with Sketch. 380
    gilead is pretty stacked on the treatment panel. wonder why Rem was chosen. weird.

    Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics

    Last Updated: June 11, 2020

    Reporting Period: May 1, 2019, to March 31, 2020

    MemberFinancial Disclosure
    CompanyRelationship
    Judith Aberg, MDGilead SciencesResearch Support
    RegeneronResearch Support
    Adaora Adimora, MD, MPHGilead SciencesConsultant, Research Support
    Jason Baker, MD, MSGilead ScienceResearch Support
    Lisa Baumann Kreuziger, MD, MS3MStockholder, spouse is an employee
    CSL BehringAdvisory Board for Non-Approved Medications
    Quercegen PharmaceuticalsAdvisory Board for Non-Approved Medications
    VersitiEmployee
    Roger Bedimo, MD, MSGilead SciencesHonoraria
    Pamela S. Belperio, PharmDNoneN/A
    Laura Bosque Ortiz, BSNoneN/A
    John T. Brooks, MDNoneN/A
    Timothy Burges, MDNoneN/A
    Stephen V. Cantrill, MDNoneN/A
    Ann C. Collier, MDNoneN/A
    Craig Coopersmith, MDNoneN/A
    Page Crew, PharmD, MPHNoneN/A
    Eric Daar, MDGilead SciencesConsultant, Research Support
    Richard T. Davey, Jr., MDNoneN/A
    Susan L. Davis, PharmDNoneN/A
    Laurie K. Doepel, BANoneN/A
    Amy L. Dzierba, PharmDNoneN/A
    Robert W. Eisinger, PhDNoneN/A
    Laura Evans, MD, MScNoneN/A
    Joseph Francis, MD, MPHNoneN/A
    Rajesh Gandhi, MDMerck & Co.Advisory Board
    David V. Glidden, PhDGilead SciencesConsultant
    Birgit Grund, PhDNoneN/A
    Roy M. Gulick, MD, MPHNoneN/A
    Erica J. Hardy, MD, MMScNoneN/A
    Elizabeth S. Higgs, MD, DTM&H, MIANoneN/A
    Brenna L. Hughes, MD, MScNoneN/A
    Steven Johnson, MDNoneN/A
    Marla J. Keller, MDNoneN/A
    Arthur Kim, MDNoneN/A
    Safia Kuriakose, PharmDNoneN/A
    H. Clifford Lane, MDNoneN/A
    Jeffrey L. Lennox, MDNoneN/A
    Andrea M. Lerner, MD, MSNoneN/A
    Mitchell M. Levy, MDNoneN/A
    Gregory Martin, MD, MScRegeneronConsultant
    Henry Masur, MDNoneN/A
    Susanna Naggie, MD, MHSAbbVieResearch Support
    Gilead SciencesResearch Support
    Vir BiotechnologyAdvisory Board, Stockholder
    Martha C. Naso, PhDNoneN/A
    Alice K. Pau, PharmDNoneN/A
    Andrew T. Pavia, MDGenentechConsultant
    Merck & Co.Consultant
    SeqirusConsultant
    Nitin Seam, MDNoneN/A
    Virginia Sheikh, MD, MHSNoneN/A
    Steven Q. Simpson, MDNoneN/A
    Kanal Singh, MD, MPHNoneN/A
    Susan Swindells, MBBSNoneN/A
    Pablo Tebas, MDGilead SciencesResearch Support
    INOVIO PharmaceuticalsResearch Support
    Phyllis Tien, MD, MScNoneN/A
    Timothy M. Uyeki, MD, MPHNoneN/A
    Alpana A. Waghmare, MDAnsun BioPharmaResearch Support
    KYORIN Pharmaceutical Co.Advisory Board
    Robert Walker, MDNoneN/A
    Kevin C. Wilson, MDNoneN/A
    https://www.covid19treatmentguidelines.nih.gov/panel-financial-disclosure/
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.